A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance

The development of standardized and reproducible clinical pathways is an important precondition for quality assurance in medicine, especially if a new method has not yet been ultimately validated. Sentinel lymph node biopsy (SLNB) is a widely accepted new surgical procedure in the treatment of early breast carcinoma. However, numerous steps of the method and details of the technique are not standardized and, thus, hamper quality assurance for SLNB. The German Society of Senology appointed an interdisciplinary consensus committee to work out guidelines for the standardized performance and quality‐assured implementation of SLNB on a nationwide, homogeneous standard. The committee consisted of surgeons, gynecologists, radiooncologists, nuclear physicians, oncologists, and pathologists. Relevant questions related to patient selection, lymphatic mapping, surgery, histopathologic work‐up, further local and systemic treatment decisions, patient information, training, and follow‐up were evaluated with respect to clinical evidence, objectivity, and reproducibility. Clinical pathways were developed on the basis of this analysis. Requirements to the performing institutions and surgeons were defined. Cancer 2005. © 2004 American Cancer Society.

[1]  K. Bloom,et al.  Occult Metastases in Sentinel Nodes of 200 Patients With Operable Breast Cancer , 2001, Annals of Surgical Oncology.

[2]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[3]  D W Kinne,et al.  Staging and follow‐up of breast cancer patients , 1991, Cancer.

[4]  Umberto Veronesi,et al.  Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA , 2002 .

[5]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[6]  A. Luini,et al.  Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. , 2003, Archives of surgery.

[7]  B. Asselain,et al.  Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Reintgen,et al.  The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. , 2004, Cancer control : journal of the Moffitt Cancer Center.

[9]  B. Rasmussen,et al.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial , 1999, The Lancet.

[10]  A. Derossis,et al.  A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. , 2001, Journal of the American College of Surgeons.

[11]  P. Tanis,et al.  The Definition of a Sentinel Node , 2001, Annals of Surgical Oncology.

[12]  T. Kühn,et al.  Impact of the axillary nodal status on sentinel node mapping in breast cancer and its relevance for technical proceeding , 2001, Breast Cancer Research and Treatment.

[13]  A. Shamiyeh,et al.  Follow‐up of sentinel node negative breast cancer patients without axillary lymph node dissection , 2001, Journal of surgical oncology.

[14]  S. Nathanson,et al.  Pathways of Lymphatic Drainage From the Breast , 2001, Annals of Surgical Oncology.

[15]  G. Farshid,et al.  Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma , 2000, Cancer.

[16]  G. Cserni.  Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients , 2002, Journal of clinical pathology.

[17]  H. Schirrmeister,et al.  Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  E. Sanidas,et al.  How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? , 2003, American journal of surgery.

[19]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[20]  D. Reintgen,et al.  Implementation of New Surgical Technology: Outcome Measures for Lymphatic Mapping of Breast Carcinoma , 1999, Annals of Surgical Oncology.

[21]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.

[22]  J. Frisell,et al.  Multicentre study of detection and false‐negative rates in sentinel node biopsy for breast cancer , 2001, The British journal of surgery.

[23]  R. Roumen,et al.  Treatment of 100 patients with sentinel node‐negative breast cancer without further axillary dissection , 2001, The British journal of surgery.

[24]  K. McMasters,et al.  Defining the Optimal Surgeon Experience for Breast Cancer Sentinel Lymph Node Biopsy: A Model for Implementation of New Surgical Techniques , 2001, Annals of surgery.

[25]  K. McMasters,et al.  Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. , 2000, Annals of surgery.

[26]  G. Hortobagyi,et al.  Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  H. Cody,et al.  Credentialing for breast lymphatic mapping: how many cases are enough? , 1999, Annals of surgery.

[28]  P. Tanis,et al.  Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. , 2001, Journal of the American College of Surgeons.

[29]  H. Ulmer,et al.  Radiotherapy of Internal Mammary Lymph Nodes in Breast Cancer Principle Considerations on the Basis of Dosimetric Data , 2002, Strahlentherapie und Onkologie.

[30]  A E Giuliano,et al.  Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  R. Roumen,et al.  In search of the true sentinel node by different injection techniques in breast cancer patients. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[32]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[33]  G. Schwartz,et al.  Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. , 2002, The breast journal.

[34]  N. Le,et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. , 1997, The New England journal of medicine.

[35]  G. Cserni.  A model for determining the optimum histology of sentinel lymph nodes in breast cancer , 2004, Journal of Clinical Pathology.

[36]  G. Cserni.  Axillary staging of breast cancer and the sentinel node , 2000, Journal of clinical pathology.

[37]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[38]  C. Hill,et al.  Is it useful to remove internal mammary nodes in operable breast cancer? , 1987, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[39]  A. Rademaker,et al.  Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. , 1999, Surgery.

[40]  G. Farshid,et al.  Removal of two sentinel nodes accurately stages the axilla in breast cancer , 2003, The British journal of surgery.

[41]  S. Korourian,et al.  Subareolar versus peritumoral injection for location of the sentinel lymph node. , 1999, Annals of surgery.

[42]  S. Edge,et al.  Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  P B Cerrito,et al.  Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  L. Tafra,et al.  Multicenter Trial of Sentinel Node Biopsy for Breast Cancer Using Both Technetium Sulfur Colloid and Isosulfan Blue Dye , 2001, Annals of surgery.

[45]  G. Cserni,et al.  Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma. , 2002, Journal of Clinical Pathology.

[46]  E. Petru,et al.  T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases , 2002, Breast Cancer Research and Treatment.

[47]  R. Gelber,et al.  Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  I. Fentiman,et al.  Occult axillary lymph node metastases are of no prognostic significance in breast cancer , 2002, British Journal of Cancer.

[49]  K. McMasters,et al.  Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. , 2001, Journal of the American College of Surgeons.

[50]  M. McCarter,et al.  The breast cancer patient with multiple sentinel nodes: when to stop? , 2001, Journal of the American College of Surgeons.

[51]  G. Hortobagyi,et al.  Proceedings of the Consensus Conference on Neoadjuvant Chemotherapy in Carcinoma of the Breast, April 26–28, 2003, Philadelphia, Pennsylvania , 2004, Cancer.

[52]  M. McCarter,et al.  Original scientific articleThe breast cancer patient with multiple sentinel nodes: when to stop?1 ☆ , 2001 .

[53]  P. V. van Diest,et al.  Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. , 2000, Annals of surgery.

[54]  K. Winzer,et al.  Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[55]  S. Love,et al.  Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. , 1990, Archives of surgery.

[56]  J. Peterse,et al.  Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. , 2003, European journal of cancer.